403 related articles for article (PubMed ID: 16417600)
21. Botulinum toxin B reduces sialorrhea in parkinsonism.
Racette BA; Good L; Sagitto S; Perlmutter JS
Mov Disord; 2003 Sep; 18(9):1059-61. PubMed ID: 14502678
[TBL] [Abstract][Full Text] [Related]
22. Reply: Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: randomized, double-blind, noninferiority trial.
Mueller J
Mov Disord; 2009 May; 24(7):1098-9; author reply 1100. PubMed ID: 18942082
[No Abstract] [Full Text] [Related]
23. Saliva changes in Parkinson's disease patients after injection of Botulinum neurotoxin type A.
Tiigimäe-Saar J; Tamme T; Rosenthal M; Kadastik-Eerme L; Taba P
Neurol Sci; 2018 May; 39(5):871-877. PubMed ID: 29460161
[TBL] [Abstract][Full Text] [Related]
24. Botulinum toxin treatment of secretory disorders.
Naumann M; Jost W
Mov Disord; 2004 Mar; 19 Suppl 8():S137-41. PubMed ID: 15027066
[TBL] [Abstract][Full Text] [Related]
25. Botulinum toxin for treatment of parkinsonian sialorrhea.
Friedman A; Potulska A
Neurol Neurochir Pol; 2001; 35 Suppl 3():23-7. PubMed ID: 12001650
[TBL] [Abstract][Full Text] [Related]
26. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
Bhidayasiri R; Cardoso F; Truong DD
Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
[TBL] [Abstract][Full Text] [Related]
27. Botulinum toxin A for treatment of sialorrhea in children: an effective, minimally invasive approach.
Khan WU; Campisi P; Nadarajah S; Shakur YA; Khan N; Semenuk D; McCann C; Roske L; McConney-Ellis S; Joseph M; Parra D; Amaral J; John P; Temple M; Connolly B
Arch Otolaryngol Head Neck Surg; 2011 Apr; 137(4):339-44. PubMed ID: 21242533
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of sialorrhea with botulinum toxin: an overview].
Hagenah J; Kahl KG; Steinlechner S; Lencer R; Klein C
Nervenarzt; 2005 Apr; 76(4):418-25. PubMed ID: 15448912
[TBL] [Abstract][Full Text] [Related]
29. Botulinum toxin in the management of sialorrhoea: a systematic review.
Lim M; Mace A; Nouraei SA; Sandhu G
Clin Otolaryngol; 2006 Aug; 31(4):267-72. PubMed ID: 16911641
[TBL] [Abstract][Full Text] [Related]
30. Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparations.
Frei K; Truong DD; Dressler D
Eur J Neurol; 2006 Feb; 13 Suppl 1():30-5. PubMed ID: 16417595
[TBL] [Abstract][Full Text] [Related]
31. Botulinum toxin is a useful treatment in excessive drooling in saliva.
Bhatia KP; Münchau A; Brown P
J Neurol Neurosurg Psychiatry; 1999 Nov; 67(5):697. PubMed ID: 10577041
[No Abstract] [Full Text] [Related]
32. [Botulinum toxin treatment in children].
Sätilä H; Vähäsarja V; Paavilainen P
Duodecim; 2011; 127(22):2417-24. PubMed ID: 22238919
[TBL] [Abstract][Full Text] [Related]
33. Evidence for the effectiveness of botulinum toxin for sialorrhoea.
Truong DD; Bhidayasiri R
J Neural Transm (Vienna); 2008; 115(4):631-5. PubMed ID: 18250951
[TBL] [Abstract][Full Text] [Related]
34. Up-to-date report of botulinum toxin therapy in patients with drooling caused by different etiologies.
Ellies M; Laskawi R; Rohrbach-Volland S; Arglebe C
J Oral Maxillofac Surg; 2003 Apr; 61(4):454-7. PubMed ID: 12684962
[TBL] [Abstract][Full Text] [Related]
35. Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series.
Jongerius PH; Rotteveel JJ; van den Hoogen F; Joosten F; van Hulst K; Gabreëls FJ
Eur J Pediatr; 2001 Aug; 160(8):509-12. PubMed ID: 11548191
[TBL] [Abstract][Full Text] [Related]
36. Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients.
Jackson CE; Gronseth G; Rosenfeld J; Barohn RJ; Dubinsky R; Simpson CB; McVey A; Kittrell PP; King R; Herbelin L;
Muscle Nerve; 2009 Feb; 39(2):137-43. PubMed ID: 19145653
[TBL] [Abstract][Full Text] [Related]
37. Treatment of sialorrhea in children with cerebral palsy: a double-blind placebo controlled trial.
Alrefai AH; Aburahma SK; Khader YS
Clin Neurol Neurosurg; 2009 Jan; 111(1):79-82. PubMed ID: 18977585
[TBL] [Abstract][Full Text] [Related]
38. Botulinum toxin B as an effective and safe treatment for neuroleptic-induced sialorrhea.
Steinlechner S; Klein C; Moser A; Lencer R; Hagenah J
Psychopharmacology (Berl); 2010 Jan; 207(4):593-7. PubMed ID: 19823807
[TBL] [Abstract][Full Text] [Related]
39. Expanding use of botulinum toxin.
Bhidayasiri R; Truong DD
J Neurol Sci; 2005 Aug; 235(1-2):1-9. PubMed ID: 15990116
[TBL] [Abstract][Full Text] [Related]
40. Salivary gland application of botulinum toxin for the treatment of sialorrhea.
Fuster Torres MA; Berini Aytés L; Gay Escoda C
Med Oral Patol Oral Cir Bucal; 2007 Nov; 12(7):E511-7. PubMed ID: 17978775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
